Order Chews-4-Health. Order today, Buy 1 Get 1 4 Free.

The 4 “Super Fruits” contained in Chews 4 Health are considered by many experts to be the most nutrient rich fruits the world has to offer. Our carefully selected super-fruit complex gives you the power of all 4 in one supplement.

Chews 4 Health Super Fruit Complex contains:
Goji, Noni, Mangosteen and Acai.
These are considered by many to be the 4 most nutrient rich fruits in the world. Our carefully selected super-fruit complex gives you the power of all 4 in just one supplement.
Anti-aging, longevity, improved mental focus, helps maintain intestinal health and immune system enhancing capabilities.*

Chews-4-Health contains 4 sea vegetables:
Kelp, Nori, Dulse and Bladderwack.
Sea vegetation is considered superior to vegetables grown on land because they do not contain the genetic modification and chemicals frequently used in farming. Land plants take carbon dioxide out of the air and make vitamins, amino acids and fatty acids. However, plants can not make minerals and, therefore, have to rely on getting minerals from the soil. When Farmers fertilize their fields with only the minimal nutrients needed to grow a crop, this can leave the soil devoid of many vital minerals needed by the body. Our Sea Vegetable blend contains up to 70 naturally occurring plant source minerals from A to Z. Sea Vegetables provide a rich source of minerals in the vegetable kingdom because they don't rely on land soil but have access to the abundance of minerals found in the ocean. Sea vegetables are virtually fat-free, low in calories and offer soluble, plant based trace elements. They also contain chlorophyll and are a good source of protein.

Vitamin B12, Folic Acid, Alpha Lipoic Acid and Resveratrol.
Heart healthy aids in the body's normal production of red blood cells, helps neutralize free radicals that may damage DNA and vital for normal human growth and development.

Chews-4-Health contains 4 select fruit concentrates:
Pomegranate, Blueberry, Cranberry and Raspberry.
These carefully selected fruits were chosen as part of the formulation because of their combined health enhancing properties.

*The statements above have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Red Yeast Rice Lowers Cholesterol: Study Backs Up Centuries of Traditional Use
(NaturalNews) Research just published in the Annals of Internal Medicine concludes a nonprescription, natural supplement -- red yeast rice -- has significant cholesterol-lowering effects. However, one important part of this story is that this isn't really a new discovery at all. Red yeast rice, a bright reddish purple fermented rice cultivated with the mold Monascus purpureus, has been used in Chinese medicine for more than a millennium to treat heart ills and other health problems.

The new study was a randomized controlled trial conducted by doctors at Chestnut Hill Hospital in Flourtown, Pennsylvania. David Becker, MD, and his research team studied 62 patients whose super high levels of low-density lipoprotein (LDL) cholesterol put them at risk for heart attack or stroke. Why weren't these people already on statin drugs, the supposedly miraculous cholesterol lowering "wonder" drugs? All of them had a history of trying those medications but had to stop them because of severe side effects often reported by statin users, including muscle pain and weakness.

Half of the research subjects were given 1,800 mg of red yeast rice twice a day for 24 weeks and the other half took inactive placebo pills. After the first 12 weeks, the study participants taking red yeast rice showed a significant improvement in their levels of artery-clogging LDL cholesterol. In fact, on average their cholesterol dropped an amazing 43 points. The placebo group had an LDL drop of only 11 points. After 24 weeks, there was a 35 point drop in "bad" cholesterol levels in the red yeast rice group. The researchers think this second cholesterol measurement showed less of a decrease than the earlier tests simply because some of the study participants may have stopped taking their supplements.

Another important finding: the "good" cholesterol, or high-density lipoprotein (HDL) count, remained the same in both groups. This indicates red rice yeast only lowers the artery damaging type of cholesterol. What's more, the red yeast rice did not produce the common side effects like elevated liver enzymes and weakness that are quite common in people taking prescription statin drugs.

In their Annals of Internal Medicine paper, the researchers concluded that while more research is needed, red yeast rice supplements may provide an alternative treatment for people with high cholesterol levels who cannot take statin drugs because of the medications' side effects.

Red yeast rice may not be totally side effect free. But side effects for the most part appear to be mild. For example, the National Institutes of Health (NIH) Medline information web site reports red yeast rice can cause mild headache and abdominal discomfort and should not be used by people with liver disease. On the other hand, reports of serious side effects from statins have continued to mount over the past few years. They range from muscle pain so severe it interferes with daily activities to serious liver damage. Moreover, as previously reported in NaturalNews, the drugs have been linked to an increase in prostate cancer in overweight men (http://www.naturalnews.com/025218_c...) and to the development of serious eye problems, too (http://www.naturalnews.com/025058_d...).

So why is red yeast rice rarely -- if ever -- prescribed while statin drugs are being taken by 11 million to 30 million Americans? Because Big Pharma has consistently fought the concept that a natural, low cost, over-the-counter product could work as well as prescription statin medications (and most likely be far safer, too). According to the NIH web site, there has been an ongoing and protracted legal and industrial dispute about whether red yeast rice is a drug or a dietary supplement involving the manufacturers of red yeast supplements, the U.S. Food and Drug Administration (FDA), and the pharmaceutical industry -- specifically Big Pharma producers of HMG-CoA reductase inhibitor prescription drugs, the official name for statins.

Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial, Becker et al. Annals of Internal Medicine.2009; 150: 830-839

For more information:
http://www.annals.org/cgi/content/a...
http://www.nlm.nih.gov/medlineplus/...
http://www.mayoclinic.com/health/re...

FDA Scientists Warn About Bleeding Risk of Bayer's Blood-Thinning Drug
by David Gutierrez, staff writer

(NaturalNews) The FDA has publicly released documents from science reviewers expressing concern over the blood-thinning drug rivaroxaban, marketed by Bayer AG and Johnson & Johnson (J&J) as Xarelto in Canada and Europe. The drug has yet to receive regulatory approval in the United States, but an application is pending.

The pill, introduced as a competitor to Sanofi-Aventis' injectable drug Lovenox (enoxaparin), is indicated for once-a-day short term use in order to prevent blood clots following hip- or knee-replacement surgeries. A series of randomized clinical trials (RECORD) on a total of 6,183 participants found Xarelto to be just effective as Lovenox, if not more so, but also that it was twice as likely to cause bleeding.

"The evidence that administration of rivaroxaban (Xarelto) could lead to bleeding events in significantly more patients relative to enoxaparin amplifies [the] safety concern for rivaroxaban," FDA staff wrote.

Concerns have also been raised over the possibility that Xarelto might increase patients' risk of liver damage. One participant in the RECORD trials died of liver toxicity. FDA staff noted that more long-term studies would be needed to gain understanding of the drug's liver risks.

Two days after the agency released its scientists' concerns, an FDA advisory panel recommended approval of the drug for short-term use, and in Europe and Canada. The panel acknowledged that Xarelto is more likely to cause bleeding than Lovenox.

Approximately 800,000 hip- and knee-replacement surgeries take place in the United States every year, providing only a relatively small market for Xarelto or Lovenox. But analysts expect Bayer and J&J to eventually seek approval for long-term use of the drug for stroke prevention. According to analysts from Morgan Stanley, sales of Xarelto for hip- and knee-replacements will likely peak at $200 million per year, yet Bayer has projected eventual annual sales of $2.6 billion for all uses.

One in Seven U.S. Teens Deficient in Vitamin D, Say Researchers
by David Gutierrez, staff writer

(NaturalNews) A full one in seven U.S. teenagers are deficient in vitamin D, according to a new analysis conducted by researchers from Cornell University, published in the journal Pediatrics and presented at the annual meeting of the Pediatric Academic Society.

"These are alarming findings," researcher Sandy Saintonge said. "We need to do a better job of educating the public on the importance of vitamin D, and the best ways to get it."

Researchers looked at 2,955 U.S. residents between the ages of 12 and 19 who were included in the National Health and Nutrition Examination Survey III, which was designed to be nationally representative. They used the new definition of vitamin D deficiency -- blood levels lowe r than 20 nanograms per milliliter -- adopted at the 13th Workshop Consensus for Vitamin D Nutritional Guidelines in 2007.

The researchers found that one in seven teenagers were vitamin D deficient, including 50 percent of black teenagers. Overweight teenagers were twice as likely to be deficient as teenagers of healthy weight, and girls had twice the risk of boys.

Vitamin D deficiency increases the risk of the bone-softening disease rickets in children, and the risk of weak bones and fractures in adults. It has also been linked to higher rates of cancer, cardiovascular disease and autoimmune disorders.

The study authors expressed particular concern over the high rates of deficiency in girls, since teenage girls are physically capable of becoming pregnant. Vitamin D deficiency during pregnancy can increase the risk of gestational high blood pressure and diabetes in mothers, and weakened bones in their children.

Approximately 75.4 of every 1,000 teenage girls in the United States becomes pregnant each year. Eighty percent of these pregnancies are unplanned.

The researchers noted that the link between vitamin D deficiency and obesity poses its own challenges

"Because vitamin D is stored in body fat, simply increasing the dosage of vitamin D may not be effective in overweight adolescents," senior author Linda M. Gerber said. "As the prevalence of childhood obesity increases, vitamin D deficiency may increase as well. In this group, appropriate nutrition could solve both problems."

The power of 4 super fruits + 4 sea vegetables + 4 super antioxidants + 4 select traditional fruits = Chews4Health Feel the Power of Chews-4-Health, order today!